Age-related neurodegenerative disease research needs aging models.
作者信息
Johnson Ian P
机构信息
Discipline of Anatomy and Pathology, Motoneurone Research Laboratory, The University of Adelaide Adelaide, SA, Australia.
出版信息
Front Aging Neurosci. 2015 Sep 2;7:168. doi: 10.3389/fnagi.2015.00168. eCollection 2015.
Abstract
摘要
相似文献
1
Age-related neurodegenerative disease research needs aging models.
Front Aging Neurosci. 2015 Sep 2;7:168. doi: 10.3389/fnagi.2015.00168. eCollection 2015.
2
Commentary: Age-related neurodegenerative disease research needs aging models.
Front Aging Neurosci. 2016 Jan 29;8:9. doi: 10.3389/fnagi.2016.00009. eCollection 2016.
3
Brain oxidative stress in animal models of accelerated aging and the age-related neurodegenerative disorders, Alzheimer's disease and Huntington's disease.
Curr Med Chem. 2001 Jun;8(7):815-28. doi: 10.2174/0929867013373048.
4
Exploring the power of yeast to model aging and age-related neurodegenerative disorders.
Biogerontology. 2017 Feb;18(1):3-34. doi: 10.1007/s10522-016-9666-4. Epub 2016 Nov 1.
5
Response: Commentary: Age-related neurodegenerative disease research needs aging models.
Front Aging Neurosci. 2016 Mar 4;8:44. doi: 10.3389/fnagi.2016.00044. eCollection 2016.
6
Frailty and Neurodegenerative Disease: Anticipating the Future, Expanding the Framework.
J Frailty Aging. 2018;7(1):57-59. doi: 10.14283/jfa.2017.46.
7
Murine models of brain aging and age-related neurodegenerative diseases.
Behav Brain Res. 1997 Apr;85(1):1-26. doi: 10.1016/s0166-4328(96)02243-7.
8
Mouse models rarely mimic the transcriptome of human neurodegenerative diseases: A systematic bioinformatics-based critique of preclinical models.
Eur J Pharmacol. 2015 Jul 15;759:101-17. doi: 10.1016/j.ejphar.2015.03.021. Epub 2015 Mar 23.
9
Aging-dependent changes of microglial cells and their relevance for neurodegenerative disorders.
J Neurochem. 2010 Mar;112(5):1099-114. doi: 10.1111/j.1471-4159.2009.06537.x. Epub 2009 Dec 10.
10
Pathology of the Aging Brain in Domestic and Laboratory Animals, and Animal Models of Human Neurodegenerative Diseases.
Vet Pathol. 2016 Mar;53(2):327-48. doi: 10.1177/0300985815623997. Epub 2016 Feb 11.
引用本文的文献
1
Molecular Duality of OGG1: From Genomic Guardian to Redox-Sensitive Modulator in Diseases.
Antioxidants (Basel). 2025 Aug 10;14(8):980. doi: 10.3390/antiox14080980.
2
Senescence- and Immunity-Related Changes in the Central Nervous System: A Comprehensive Review.
Aging Dis. 2024 Aug 26;16(4):2177-2200. doi: 10.14336/AD.2024.0755.
3
Glycosylation in aging and neurodegenerative diseases.
Acta Biochim Biophys Sin (Shanghai). 2024 Aug 15;56(8):1208-1220. doi: 10.3724/abbs.2024136.
4
Metabolic Disturbances in a Mouse Model of MPTP/Probenecid-Induced Parkinson's Disease: Evaluation Using Liquid Chromatography-Mass Spectrometry.
Neuropsychiatr Dis Treat. 2024 Aug 27;20:1629-1639. doi: 10.2147/NDT.S471744. eCollection 2024.
5
Tumor Suppressor MicroRNAs in Clinical and Preclinical Trials for Neurological Disorders.
Pharmaceuticals (Basel). 2024 Mar 27;17(4):426. doi: 10.3390/ph17040426.
6
Bioactive Compounds of the Mediterranean Diet as Nutritional Support to Fight Neurodegenerative Disease.
Int J Mol Sci. 2023 Apr 15;24(8):7318. doi: 10.3390/ijms24087318.
7
Alternative transcribed 3' isoform of long non-coding RNA inhibits mouse retinal oxidative stress.
iScience. 2022 Dec 5;26(1):105740. doi: 10.1016/j.isci.2022.105740. eCollection 2023 Jan 20.
8
Brain organoid-on-a-chip: A next-generation human brain avatar for recapitulating human brain physiology and pathology.
Biomicrofluidics. 2022 Nov 23;16(6):061301. doi: 10.1063/5.0121476. eCollection 2022 Dec.
9
Accelerated neuronal aging ∼melting watch ∼.
Front Aging Neurosci. 2022 Aug 9;14:868770. doi: 10.3389/fnagi.2022.868770. eCollection 2022.
10
Aging Promotes Chronic Stress-Induced Depressive-Like Behavior by Activating NLRP1 Inflammasome-Driven Inflammatory Signaling in Mice.
Inflammation. 2022 Dec;45(6):2172-2185. doi: 10.1007/s10753-022-01683-4. Epub 2022 Jul 2.
本文引用的文献
1
From mice to mind: Strategies and progress in translating neuroregeneration.
Eur J Pharmacol. 2015 Jul 15;759:90-100. doi: 10.1016/j.ejphar.2015.03.041. Epub 2015 Mar 23.
2
Parkinson's disease: animal models and dopaminergic cell vulnerability.
Front Neuroanat. 2014 Dec 15;8:155. doi: 10.3389/fnana.2014.00155. eCollection 2014.
3
Animal models of dementia and cognitive dysfunction.
Life Sci. 2014 Jul 30;109(2):73-86. doi: 10.1016/j.lfs.2014.05.017. Epub 2014 Jun 2.
4
Ageing and Parkinson's disease: why is advancing age the biggest risk factor?
Ageing Res Rev. 2014 Mar;14(100):19-30. doi: 10.1016/j.arr.2014.01.004. Epub 2014 Feb 3.
5
Amyotrophic Lateral Sclerosis: An update for 2013 Clinical Features, Pathophysiology, Management and Therapeutic Trials.
Aging Dis. 2013 Oct 1;4(5):295-310. doi: 10.14336/AD.2013.0400295.
6
The worldwide economic impact of dementia 2010.
Alzheimers Dement. 2013 Jan;9(1):1-11.e3. doi: 10.1016/j.jalz.2012.11.006.
7
Drug therapy in patients with Parkinson's disease.
Transl Neurodegener. 2012 May 24;1(1):10. doi: 10.1186/2047-9158-1-10.
8
Current advances in using neurotrophic factors to treat neurodegenerative disorders.
Transl Neurodegener. 2012 Jul 26;1(1):14. doi: 10.1186/2047-9158-1-14.
9
Amyotrophic lateral sclerosis: drug therapy from the bench to the bedside.
Semin Neurol. 2012 Jul;32(3):173-8. doi: 10.1055/s-0032-1329193. Epub 2012 Nov 1.
10
The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease (review of Technology Appraisal No. 111): a systematic review and economic model.
Health Technol Assess. 2012;16(21):1-470. doi: 10.3310/hta16210.
Zotero 插件